Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Hydrochloride, Oxymetazoline
2. Oxymetazoline
1. 2315-02-8
2. Oxymetazoline Hcl
3. Ocuclear
4. Afrazine
5. Afrin Hydrochloride
6. Sch 9384
7. Rhofade
8. Oxymetazoline (hydrochloride)
9. Visine L.r.
10. Vicks Sinex
11. Nsc-757254
12. K89mj0s5vy
13. 6-tert-butyl-3-(4,5-dihydro-1h-imidazol-2-ylmethyl)-2,4-dimethylphenol;hydrochloride
14. Mls000038040
15. Chebi:7863
16. Agn-199201
17. Sch-9384
18. Smr000059324
19. 2-(4-t-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazolinium Chloride
20. 2,6-dimethyl-2-(4-tertiarybutyl-3-hydroxyphenyl)methylimidazoline Hydrochloride
21. 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol Monohydrochloride
22. 6-tert-butyl-3-(4,5-dihydro-1h-imidazol-2-ylmethyl)-2,4-dimethylphenol Hydrochloride
23. Phenol, 3-((4,5-dihydro-1h-imidazol-2-yl)methyl)-6-(1,1-dimethylethyl)-2,4-dimethyl-, Monohydrochloride
24. 2-(3-hydroxy-2,6-dimethyl-4-tert-butylbenzyl)-2-imidazoline
25. Lliadine
26. Nasivin
27. Nasivine
28. Neonabel
29. Nostrilla
30. Nafrine Hydrochloride
31. 4-way Nasal Spray
32. Duration Nasal Spray
33. Oxymetazoline Chloride
34. Lliadin Mini Paediatric
35. Sr-01000002705
36. Neo-synephrine 12 Hour
37. Neo-synephrine 12 Hour Ntz
38. Sinex
39. Anefrin Nasal
40. Duration 12 Hour Nasal Spray
41. Benzedrex Nasal Spray 12 Hour
42. Dristan Long Lasting Nasal Mist
43. Sudafed Om
44. Ocuclear (tn)
45. Prestwick_373
46. Einecs 219-015-0
47. St. Joseph Nasal Spray For Children
48. Mfcd00058147
49. Rhfade (tn)
50. Upneeq
51. Opera_id_32
52. 2-(3-hydroxy-2,6-dimethyl-4-t-butylbenzyl)-2-imidazoline Hydrochloride
53. Unii-k89mj0s5vy
54. 3-[(4,5-dihydro-
55. Schembl41247
56. Mls002222207
57. Spectrum1500453
58. Oxymetazoline Hydrochloride,(s)
59. Chembl1200791
60. Hy-b0427a
61. Dtxsid80177729
62. Oximetazoline Hydrochloride
63. Hms1568n09
64. Hms1920d18
65. Pharmakon1600-01500453
66. Tox21_500903
67. Ccg-40216
68. Nsc757254
69. 6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol Hydrochloride
70. Akos000280887
71. Oxymetazoline Hydrochloride (jan/usp)
72. Phenol, 6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-, Hydrochloride
73. Ks-5222
74. Lp00903
75. Nsc 757254
76. Oxymetazoline Hydrochloride [mi]
77. Ncgc00094218-01
78. Ncgc00094218-02
79. Ncgc00094218-03
80. Ncgc00094218-04
81. Ncgc00094218-05
82. Ncgc00261588-01
83. Oxymetazoline Hydrochloride [jan]
84. 2315-02-8 (hcl)
85. Oxymetazoline Hydrochloride [usan]
86. Oxymetazoline Hydrochloride [mart.]
87. Oxymetazoline Hydrochloride [vandf]
88. 4-(2-boc-amino-pyridin-4-yl)-benzoicacid
89. Oxymetazoline Hydrochloride [who-dd]
90. Oxymetazoline Hydrochloride, >=99%, Solid
91. Eu-0100903
92. Ft-0673462
93. O0520
94. Oxymetazoline Hydrochloride [usan:usp:jan]
95. Sw196632-3
96. D01022
97. D91882
98. O 2378
99. Oxymetazoline Hydrochloride, Analytical Standard
100. Oxymetazoline Hydrochloride [orange Book]
101. 315o028
102. A910982
103. Oxymetazoline Hydrochloride [ep Monograph]
104. Oxymetazoline Hydrochloride [usp Impurity]
105. Oxymetazoline Hydrochloride [usp Monograph]
106. Kovanaze Component Oxymetazoline Hydrochloride
107. Sr-01000002705-2
108. Sr-01000002705-4
109. Sr-01000002705-7
110. W-107424
111. Q27107602
112. Oxymetazoline Hydrochloride Component Of Kovanaze
113. Sinex Vapospray Moisturizing 12-hour Decongestant Ultrafine Mist
114. 2,6-dimethyl-4-tertiarybutyl-3-hydroxyphenyl)methylimidazoline Hydrochloride
115. 2-(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazolinium Chloride
116. 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol Hydrochloride
117. Oxymetazoline Hydrochloride, European Pharmacopoeia (ep) Reference Standard
118. 1h-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol Hydrochloride
119. 2-(3-hydroxy-2,6-dimethyl-4-tert-butylbenzyl)-2-imidazoline Hydrochloride
120. 2-(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)-4,5-dihydro-1h-imidazol-1-ium Chloride
121. 6-(tert-butyl)-3-((4,5-dihydro-1h-imidazol-2-yl)methyl)-2,4-dimethylphenol Hydrochloride
122. 6-tert-butyl-3-((4,5-dihydro-1h-imidazol-2-yl)methyl)-2,4-dimethylphenol Hydrochloride
123. Oxymetazoline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
124. Oxymetazoline Hydrochloride, United States Pharmacopeia (usp) Reference Standard
125. 3-[(4,5-dihydro-1h-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl-phenol Hydrochloride
Molecular Weight | 296.83 g/mol |
---|---|
Molecular Formula | C16H25ClN2O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Exact Mass | 296.1655411 g/mol |
Monoisotopic Mass | 296.1655411 g/mol |
Topological Polar Surface Area | 44.6 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 345 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Nasal Decongestants
Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) (See all compounds classified as Nasal Decongestants.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Adrenergic alpha-Agonists
Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
35
PharmaCompass offers a list of Oxymetazoline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxymetazoline Hydrochloride manufacturer or Oxymetazoline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxymetazoline Hydrochloride manufacturer or Oxymetazoline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Oxymetazoline Hydrochloride API Price utilized in the formulation of products. Oxymetazoline Hydrochloride API Price is not always fixed or binding as the Oxymetazoline Hydrochloride Price is obtained through a variety of data sources. The Oxymetazoline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A OCUCLEAR manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of OCUCLEAR, including repackagers and relabelers. The FDA regulates OCUCLEAR manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. OCUCLEAR API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of OCUCLEAR manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A OCUCLEAR supplier is an individual or a company that provides OCUCLEAR active pharmaceutical ingredient (API) or OCUCLEAR finished formulations upon request. The OCUCLEAR suppliers may include OCUCLEAR API manufacturers, exporters, distributors and traders.
click here to find a list of OCUCLEAR suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A OCUCLEAR DMF (Drug Master File) is a document detailing the whole manufacturing process of OCUCLEAR active pharmaceutical ingredient (API) in detail. Different forms of OCUCLEAR DMFs exist exist since differing nations have different regulations, such as OCUCLEAR USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A OCUCLEAR DMF submitted to regulatory agencies in the US is known as a USDMF. OCUCLEAR USDMF includes data on OCUCLEAR's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The OCUCLEAR USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of OCUCLEAR suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The OCUCLEAR Drug Master File in Japan (OCUCLEAR JDMF) empowers OCUCLEAR API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the OCUCLEAR JDMF during the approval evaluation for pharmaceutical products. At the time of OCUCLEAR JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of OCUCLEAR suppliers with JDMF on PharmaCompass.
A OCUCLEAR CEP of the European Pharmacopoeia monograph is often referred to as a OCUCLEAR Certificate of Suitability (COS). The purpose of a OCUCLEAR CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of OCUCLEAR EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of OCUCLEAR to their clients by showing that a OCUCLEAR CEP has been issued for it. The manufacturer submits a OCUCLEAR CEP (COS) as part of the market authorization procedure, and it takes on the role of a OCUCLEAR CEP holder for the record. Additionally, the data presented in the OCUCLEAR CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the OCUCLEAR DMF.
A OCUCLEAR CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. OCUCLEAR CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of OCUCLEAR suppliers with CEP (COS) on PharmaCompass.
A OCUCLEAR written confirmation (OCUCLEAR WC) is an official document issued by a regulatory agency to a OCUCLEAR manufacturer, verifying that the manufacturing facility of a OCUCLEAR active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting OCUCLEAR APIs or OCUCLEAR finished pharmaceutical products to another nation, regulatory agencies frequently require a OCUCLEAR WC (written confirmation) as part of the regulatory process.
click here to find a list of OCUCLEAR suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing OCUCLEAR as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for OCUCLEAR API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture OCUCLEAR as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain OCUCLEAR and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a OCUCLEAR NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of OCUCLEAR suppliers with NDC on PharmaCompass.
OCUCLEAR Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of OCUCLEAR GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right OCUCLEAR GMP manufacturer or OCUCLEAR GMP API supplier for your needs.
A OCUCLEAR CoA (Certificate of Analysis) is a formal document that attests to OCUCLEAR's compliance with OCUCLEAR specifications and serves as a tool for batch-level quality control.
OCUCLEAR CoA mostly includes findings from lab analyses of a specific batch. For each OCUCLEAR CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
OCUCLEAR may be tested according to a variety of international standards, such as European Pharmacopoeia (OCUCLEAR EP), OCUCLEAR JP (Japanese Pharmacopeia) and the US Pharmacopoeia (OCUCLEAR USP).